These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 1898969)

  • 21. Antibodies to recombinant HIV-1 nef protein detected in HIV-1 infection as well as in nonrisk individuals.
    Ranki A; Järvinen K; Valle SL; Nurmilaakso P; Krohn K
    J Acquir Immune Defic Syndr (1988); 1990; 3(4):348-55. PubMed ID: 2179525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody response to the negative regulatory factor (nef) in experimentally infected macaques: correlation with viremia, disease progression, and seroconversion to structural viral proteins.
    Kirchhoff F; Voss G; Nick S; Stahl-Hennig C; Coulibaly C; Frank R; Jentsch KD; Hunsmann G
    Virology; 1991 Jul; 183(1):267-72. PubMed ID: 1675823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation in rhesus macaques of Tat and rev-targeted immunization as a preventive vaccine against mucosal challenge with SHIV-BX08.
    Verrier B; Le Grand R; Ataman-Onal Y; Terrat C; Guillon C; Durand PY; Hurtrel B; Aubertin AM; Sutter G; Erfle V; Girard M
    DNA Cell Biol; 2002 Sep; 21(9):653-8. PubMed ID: 12396607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low or no antibody responses to human immunodeficiency virus type 1 Nef in infected carriers with subtype E, in contrast to subtype B that showed antibodies preferentially recognizing subtype-specific Nef epitopes.
    Komoto S; Kinomoto M; Ibrahim MS; Zhong Q; Auwanit W; Ayuthaya PI; Otake T; Mori H; Oishi I; Kurosu T; Takahashi H; Mukai T; Ikuta K
    Vaccine; 2001 Apr; 19(20-22):3019-32. PubMed ID: 11282214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relation between humoral responses to HIV gag and env proteins at seroconversion and clinical outcome of HIV infection.
    Cheingsong-Popov R; Panagiotidi C; Bowcock S; Aronstam A; Wadsworth J; Weber J
    BMJ; 1991 Jan; 302(6767):23-6. PubMed ID: 1899349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dynamics of the antibody response and p24 antigenemia in HIV-1 infected individuals in Czechoslovakia].
    Kopecká D; Brůcková M; Stanková M; Syrůcek L; Vojtĕchovský K; Petkov V
    Cesk Epidemiol Mikrobiol Imunol; 1990 Mar; 39(2):65-73. PubMed ID: 2142624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreasing levels of anti-Nef antibody correlate with increasing HIV type 1 viral loads and AIDS disease progression.
    Chen YM; Lin RH; Lee CM; Fu CY; Chen SC; Syu WJ
    AIDS Res Hum Retroviruses; 1999 Jan; 15(1):43-50. PubMed ID: 10024051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal patterns of human immunodeficiency virus type 1 transcripts in human fetal astrocytes.
    Tornatore C; Meyers K; Atwood W; Conant K; Major E
    J Virol; 1994 Jan; 68(1):93-102. PubMed ID: 8254781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody against human immunodeficiency virus type 1 (HIV-1) Tat protein may have influenced the progression of AIDS in HIV-1-infected hemophiliac patients.
    Re MC; Furlini G; Vignoli M; Ramazzotti E; Zauli G; La Placa M
    Clin Diagn Lab Immunol; 1996 Mar; 3(2):230-2. PubMed ID: 8991642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxic T lymphocyte response against multiple simian immunodeficiency virusA (SIV) proteins in SIV-infected macaques.
    Venet A; Bourgault I; Aubertin AM; Kiény MP; Levy JP
    J Immunol; 1992 May; 148(9):2899-908. PubMed ID: 1349322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relevance of anti-nef antibody detection as an early serologic marker of human immunodeficiency virus infection.
    Bahraoui E; Benjouad A; Sabatier JM; Allain JP; Laurian Y; Montagnier L; Gluckman JC
    Blood; 1990 Jul; 76(1):257-64. PubMed ID: 1694699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant human Fab antibody fragments to HIV-1 Rev and Tat regulatory proteins: direct selection from a combinatorial phage display library.
    Pilkington GR; Duan L; Zhu M; Keil W; Pomerantz RJ
    Mol Immunol; 1996; 33(4-5):439-50. PubMed ID: 8676895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The rationale behind a vaccine based on multiple HIV antigens.
    Rollman E; Bråve A; Boberg A; Gudmundsdotter L; Engström G; Isaguliants M; Ljungberg K; Lundgren B; Blomberg P; Hinkula J; Hejdeman B; Sandström E; Liu M; Wahren B
    Microbes Infect; 2005 Nov; 7(14):1414-23. PubMed ID: 16257558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants.
    Fischer W; Perkins S; Theiler J; Bhattacharya T; Yusim K; Funkhouser R; Kuiken C; Haynes B; Letvin NL; Walker BD; Hahn BH; Korber BT
    Nat Med; 2007 Jan; 13(1):100-6. PubMed ID: 17187074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Course of specific T lymphocyte cytotoxicity, plasma and cellular viral loads, and neutralizing antibody titers in 17 recently seroconverted HIV type 1-infected patients.
    Legrand E; Pellegrin I; Neau D; Pellegrin JL; Ragnaud JM; Dupon M; Guillemain B; Fleury HJ
    AIDS Res Hum Retroviruses; 1997 Nov; 13(16):1383-94. PubMed ID: 9359658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of cellular immune responses in subjects chronically infected with HIV type 1.
    Fu TM; Dubey SA; Mehrotra DV; Freed DC; Trigona WL; Adams-Muhler L; Clair JH; Evans TG; Steigbigel R; Jacobson JM; Goepfert PA; Mulligan MJ; Kalams SA; Rinaldo C; Zhu L; Cox KS; Guan L; Long R; Persaud N; Caulfield MJ; Sadoff JC; Emini EA; Thaler S; Shiver JW
    AIDS Res Hum Retroviruses; 2007 Jan; 23(1):67-76. PubMed ID: 17263635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma viremia in human immunodeficiency virus infection.
    Coombs RW; Collier AC; Allain JP; Nikora B; Leuther M; Gjerset GF; Corey L
    N Engl J Med; 1989 Dec; 321(24):1626-31. PubMed ID: 2511447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia.
    Ranki A; Nyberg M; Ovod V; Haltia M; Elovaara I; Raininko R; Haapasalo H; Krohn K
    AIDS; 1995 Sep; 9(9):1001-8. PubMed ID: 8527071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A DNA HIV-1 vaccine based on a fusion gene expressing non-structural and structural genes of consensus sequence of the A-C subtypes and the ancestor sequence of the F-H subtypes. Preclinical and clinical studies.
    Krohn K; Stanescu I; Blazevic V; Vesikari T; Ranki A; Ustav M
    Microbes Infect; 2005 Nov; 7(14):1405-13. PubMed ID: 16257560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An ELISA-inhibition assay for antibody to human immunodeficiency virus core antigen (p24).
    Povolotsky J; Gold JW; Darminin P; Chein N; Baron P; Armstrong D
    J Virol Methods; 1990 Oct; 30(1):109-14. PubMed ID: 2128300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.